Bioluminux Clinical Research Spalding

Our Spalding research site extends Bioluminux’s clinical research capabilities across Lincolnshire and surrounding communities, providing access to both urban and rural patient populations. The site supports Phase 2–4 industry-sponsored clinical trials across a broad range of therapeutic areas.

With strong community engagement, local healthcare relationships, and experienced clinical research oversight, Spalding delivers responsive study execution, effective patient recruitment, and a commitment to high-quality clinical research for sponsors and CROs.